SAMANEH YOUSEFI: Open Payments
NPI 1316513674 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 28 payments from 12 companies in 2025. Trend: 2023 $1,680 · 2024 $1,752 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $293 |
| ARGENX US, INC. | 3 | $94 |
| Janssen Biotech, Inc. | 2 | $66 |
| JAZZ PHARMACEUTICALS INC. | 2 | $44 |
| ABBVIE INC. | 2 | $40 |
| CSL Behring | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
Products named: Rystiggo, Fintepla, VYVGART HYTRULO, XYWAV, Hizentra, QULIPTA, Symbravo, WAINUA.
Industry payments across CA — which companies pay providers there.
